Epirus Biopharmaceuticals
closedDate | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
$8.1m | Post IPO Equity | ||
$5.0m | Post IPO Equity | ||
$36.0m | Post IPO Equity | ||
* | N/A | $44.2m | Post IPO Equity |
Total Funding | - |
Recent News about Epirus Biopharmaceuticals
EditEpirus Biopharma is dedicated to providing comprehensive information on pharmaceuticals and health supplements aimed at improving mental and physical health. The company focuses on educating consumers about the benefits and informed use of these products, particularly in relation to thyroid health and its impact on overall well-being. Epirus Biopharma operates in the health and wellness market, targeting individuals seeking to enhance their quality of life through informed health choices. The business model revolves around content creation and dissemination, leveraging the latest research and trends in the health industry to attract and retain a dedicated audience. Revenue is generated through advertising, partnerships, and possibly affiliate marketing with health supplement providers.
Keywords: pharmaceuticals, health supplements, thyroid health, mental well-being, physical well-being, consumer education, health industry, content creation, advertising, partnerships.